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Abstract We have identified a novel Jun N-terminal kinase
(JNK)-binding protein, termed JNKBP1, and examined its
binding affinity for JNK1, JNK2, JNK3, and extracellular
signal-regulated kinase 2 (ERK2) in COS-7 cells. JNKBP1
preferentially interacted with the JNKs, but not with ERK2.
Furthermore, we investigated the effect of overexpressing
JNKBP1 on the JNK and ERK signaling pathways in COS-7
cells. JNKBP1 alone had only a marginal effect on JNK activity.
However, the activation of JNK by MEK kinase 1 and TGF-L-
activated kinase 1 was significantly enhanced in the presence of
JNKBP1. In contrast, JNKBP1 had no or very little effect on the
ERK signaling pathway. These results suggest that JNKBP1
functions to facilitate the specific and efficient activation of the
JNK signaling pathways.
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1. Introduction
Mitogen-activated protein kinase (MAPK) cascades, which
consist of MAPK, MAPK kinase (MAPKK), and MAPKK
kinase (MAPKKK) as the major components, are conserved
eukaryotic signaling pathways [1^4]. MAPK is activated by
dual phosphorylation on threonine and tyrosine residues cat-
alyzed by MAPKK, and MAPKK is activated by serine/
threonine phosphorylation catalyzed by MAPKKK. The Jun
N-terminal kinases (JNKs) represent a group of MAPKs that
are strongly activated by proin£ammatory cytokines, such as
interleukin 1 (IL-1) and tumor necrosis factor K (TNFK), and
extracellular stresses, such as UV irradiation and osmotic
shock [5^7]. In the JNK cascades MAPKs are JNK1,
JNK2, and JNK3 (also known as SAPKQ, SAPKK, and
SAPKL, respectively) [8^12], and MAPKKs are SEK1 (also
known as MKK4 and JNKK1) [13^15] and MKK7 (also
known as JNKK2) [16^18]. A number of protein kinases,
including apoptosis signal-regulating kinase 1 (ASK1) [19],
MEK kinase 1 (MEKK1) [20^22], mixed lineage kinase 3
(MLK3) [23], and TGF-L-activated kinase 1 (TAK1) [24],
have been identi¢ed as MAPKKKs in the JNK cascades.
The extracellular signal-regulated kinases (ERKs) represent
another group of MAPKs, which are mostly responsive to
mitogenic and di¡erentiation stimuli [25]. In the ERK cas-
cades, ERK (ERK1 and ERK2), MEK (MEK1 and
MEK2), and Raf (Raf-1, A-Raf, B-Raf) correspond to
MAPK, MAPKK, and MAPKKK, respectively [7]. The iden-
ti¢cation of numerous components of the MAPK cascades
suggests that there are a number of these distinct signaling
pathways in cells. To date, however, the molecular mechanism
by which the speci¢city and e⁄ciency of the MAPK cascades
is maintained remains unclear.
As a step toward clarifying this mechanism, we searched for
proteins that interact with JNK. In the present study we mo-
lecularly cloned a novel JNK-binding protein, termed
JNKBP1, and examined its binding a⁄nity for JNK and
ERK MAPKs. We further investigated the e¡ect of overex-
pressing JNKBP1 on the JNK and ERK cascades.
2. Materials and methods
2.1. Two-hybrid screening and isolation of JNKBP1 cDNA
The entire coding sequence of mouse JNK3 was inserted into the
pAS2 vector (Clontech). A mouse brain cDNA library in pGAD10
(Clontech) was transfected into the yeast strain CG1945 harboring
pAS2-JNK3. The Clontech yeast two-hybrid system was used accord-
ing to the manufacturer’s instructions. A ZAPII mouse brain cDNA
library (Stratagene) was screened using the partial JNKBP1 cDNA
fragment, obtained from the yeast two-hybrid system, as a probe.
2.2. Northern blotting analysis
Northern blotting analysis was performed as described previously
[26] using 32P-labeled JNKBP1 and L-actin cDNA probes.
2.3. Plasmid construction
JNK1, JNK2, and JNK3 cDNAs were isolated from a ZAPII
mouse brain cDNA library, and MEKK1 cDNA from a ZAPII
mouse spleen cDNA library (Stratagene). TAK1 cDNA was a gener-
ous gift from K. Matsumoto. The full-length human Raf-1 cDNA was
obtained from Health Science Research Resources Bank, Japan. The
ORF of ERK2 was ampli¢ed by polymerase chain reaction from
human lymphocyte cDNA. To prepare glutathione S-transferase
(GST)-JNK3 fusion protein, the entire coding sequence of mouse
JNK3 was inserted into the pGEX-2T vector (Pharmacia). For in
vitro translation, the entire or portions of the coding sequence of
JNKBP1 were inserted into a modi¢ed pcDNA3 vector (Invitrogen)
encoding a histidine (His) tag and an S tag (Novagen). To construct
mammalian expression vectors for His-S-MAPKs and His-S-MEKK1,
the entire coding sequences were inserted into the modi¢ed pcDNA3-
His-S vector. For the expression of Myc-JNKBP1 (residues 1^1508
and 1063^1331), the entire or portions of the coding sequence of
JNKBP1 was inserted into a modi¢ed pcDNA3 vector encoding a
Myc tag. The expression vectors of full-length TAK1 and truncated
Raf-1 (vRaf; residues 316^648) were constructed using a modi¢ed
pcDNA3 vector encoding a Flag tag.
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2.4. Analyses of protein-protein interactions in vitro and in vivo
GST and GST-JNK3 proteins were expressed in Escherichia coli
and puri¢ed with glutathione-agarose according to the manufacturer’s
instructions. The entire and various portions of JNKBP1 ORF were
translated in vitro in the presence of [35S]methionine using the TNT
T7 Quick Coupled Transcription/Translation System (Promega). The
35S-labeled JNKBP1 proteins were mixed with either immobilized
GST or GST-JNK3 in bu¡er A (20 mM HEPES pH 7.5, 50 mM
NaCl, 0.5 mM EGTA, and 1% NP-40), rotated for 2 h at 4‡C,
spun, and washed three times with bu¡er A. The precipitates were
separated by SDS-PAGE and subjected to autoradiography. For the
analysis of protein-protein interactions in intact cells, the expression
vectors were cotransfected into COS-7 cells with FuGENE6 (Boeh-
ringer Mannheim) according to the manufacturer’s instructions. After
34 h, cells were lysed in bu¡er B (50 mM HEPES pH 7.5, 150 mM
NaCl, 1% NP-40, 10% glycerol, 2 mM MgCl2, 1 mM EGTA, 20 mM
L-glycerophosphate, 2 mM Na3VO4, 1 mM PMSF, and 0.2 mM
DTT), and precipitated by S-protein agarose. The recovered fractions
were separated by SDS-PAGE, and transferred to Immobilon-P
(Millipore). The membranes were probed with anti-Myc 9E10 mono-
clonal antibody (Boehringer Mannheim), and visualized with the ECL
detection system (Amersham). Expression of His-S-MAPKs was ex-
amined by immunoblotting cell lysates with anti-His polyclonal anti-
body (Santa Cruz).
2.5. Reporter assay
5XGAL4-LUC reporter (Stratagene), GAL4-c-Jun or -Elk1 expres-
sion vector (Stratagene), and the expression vectors (see Fig. 4) were
transiently transfected with FuGENE6 transfection reagent. After
34 h, the cells were harvested and their luciferase activity was meas-
ured. All transfections were standardized by cotransfecting a Renilla
luciferase control vector (Promega).
3. Results and discussion
We used a yeast two-hybrid system to search for proteins
that directly interact with JNK3. A positive clone encoding a
protein, termed JNKBP1, was identi¢ed by screening approx-
imately 2U106 transformants. To isolate overlapping cDNAs
encompassing the entire open reading frame (ORF), we
screened a mouse brain cDNA library with a partial JNKBP1
cDNA insert obtained from the yeast two-hybrid system. The
full-length JNKBP1 cDNA was found to encode a protein of
1508 amino acids with a calculated relative molecular mass of
163 985 (Fig. 1A). Database searches suggested that JNKBP1
represents a mouse homologue of KIAA0596 (accession num-
ber AB011168), identi¢ed by the Kazusa cDNA project. No
function has yet been ascribed to this human gene. JNKBP1
contains four WD40 repeats [27] (see Fig. 1A). We analyzed
the tissue distributions of mouse JNKBP1 by Northern blot-
ting analysis. The results indicate that the approximately 5.8-
kb JNKBP1 mRNA is ubiquitously expressed at a very high
level in brain (Fig. 1B).
To de¢ne the region of JNKBP1 that is responsible for its
interaction with JNK, the entire and various portions of
JNKBP1 ORF were translated in vitro in the presence of
[35S]methionine. The JNKBP1 proteins were mixed with glu-
tathione-agarose bound to either GST or GST-JNK3, recov-
ered, and analyzed by SDS-PAGE and autoradiography (Fig.
2). The results indicate that the JNK-binding region is located
between residues 1063 and 1331 in JNKBP1. This region is
almost completely overlapped with the region isolated using
the yeast two-hybrid system (residues 1042^1331).
We next examined the binding a⁄nity of JNKBP1 for JNK
and ERK MAPKs using cotransfection experiments in COS-7
cells (Fig. 3). When full-length JNKBP1 was expressed in
these cells, the expression level of the full-length protein was
not high. We therefore expressed a Myc epitope-tagged por-
tion of JNKBP1 (Myc-JNKBP1; residues 1063^1331), which
contains the JNK-binding domain, and examined its ability to
bind with His-S-tagged JNK1, JNK2, JNK3, or ERK2 (His-
S-JNK1, -JNK2, -JNK3, and -ERK2, respectively) in COS-7
cells. The His-S-MAPK proteins were recovered from the cell
lysates by a⁄nity binding to S-protein agarose, and the pre-
cipitates were examined for the presence of the Myc-JNKBP1
protein by immunoblotting with an anti-Myc antibody.
JNK1, JNK2, and JNK3 interacted with JNKBP1, while no
(or very little) binding of ERK2 was observed under our assay
conditions. JNK2 showed higher binding a⁄nity to JNKBP1
than did JNK1 or JNK3.
We further examined the e¡ect of overexpressing full-length
JNKBP1 on the JNK cascades in COS-7 cells (Fig. 4A). The
JNK activity in the transfected cells was detected by measur-
ing the transcriptional activity of a GAL4-c-Jun (residues 1^
223) fusion protein containing the c-Jun activation domain.
Overexpression of full-length JNKBP1 had only a marginal
Fig. 1. A: Deduced amino acid sequence of JNKBP1. The region
isolated using the yeast two-hybrid system (residues 1042^1331) is
shown by angled arrows. The nucleotide sequence of mouse
JNKBP1 has been submitted to DDBJ/EMBL/GenBank with acces-
sion number AB029482. The four copies of the WD40 repeats are
underlined. B: Expression of JNKBP1 mRNA in mouse tissues.
Poly(A) RNA samples isolated from various mouse tissues were
examined by Northern blotting analysis. The positions of 28S and
18S rRNAs are indicated on the left. L-Actin mRNA was included
as a loading control.
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e¡ect on JNK activity. MEKK1 and TAK1, MAPKKKs in
the JNK cascades, activated JNK by 3.0- and 3.2-fold, respec-
tively, under our assay conditions. Interestingly, the activation
of JNK by MEKK1 and TAK1 was further enhanced in the
presence of JNKBP1 by 2.7- and 3.0-fold, respectively. We
also examined the e¡ect of overexpressing full-length JNKBP1
on the ERK cascade in transfected COS-7 cells (Fig. 4B). The
ERK activity in the cells was detected by measuring the tran-
scriptional activity of a GAL4-Elk1 (residues 307^427) fusion
protein containing the Elk1 activation domain. Overexpres-
sion of full-length JNKBP1 had no or very little e¡ect on
ERK activity, nor did it a¡ect the activation of ERK by
truncated Raf-1 (vRaf; residues 316^648), a constitutively
active Raf-1 [28].
As JNKBP1 seems not to possess a kinase domain, it is
unlikely that JNKBP1 directly activates the component(s) of
the JNK cascades by phosphorylation. Recently, Whitmarsh
et al. [29] reported that the JIP-1 protein plays a sca¡olding
role, where it facilitates the speci¢c and e⁄cient activation of
JNK cascades. JNKBP1 is likely to play a similar role. The
JIP-1 sca¡old protein binds multiple components of the JNK
signaling pathway, including the JNK MAPK, the MKK7
MAPKK, and the MLK3 MAPKKK. Thus, it should be
Fig. 2. Mapping of JNK-binding region in JNKBP1. The entire and
various portions of JNKBP1 ORF were translated in vitro in the
presence of [35S]methionine. The 35S-labeled JNKBP1 proteins were
incubated with 1 Wg of either immobilized GST (lanes 1, 3, 5, 7,
and 9) or GST-JNK3 (lanes 2, 4, 6, 8, and 10). The protein com-
plexes were extensively washed and the bound JNKBP1 proteins
were detected by SDS-PAGE and autoradiography. One fourth of
each 35S-labeled JNKBP1 protein used in the binding reaction was
loaded as a control. The positions of molecular weight markers are
indicated on the left.
Fig. 3. Binding of JNKBP1 to JNK and ERK MAPKs. COS-7 cells
were transiently transfected with 0.5 Wg of pcDNA3-Myc-JNKBP1
with 1.5 Wg of pcDNA3-His-S empty vector, pcDNA3-His-S-JNK1,
-JNK2, -JNK3, or -ERK2, as indicated. Cell lysates were precipi-
tated with S-protein-linked agarose (S-PA), and analyzed by immu-
noblotting with an antibody to Myc. Expression of Myc-JNKBP1
and His-S-MAPKs was examined by immunoblotting one tenth of
the cell lysates used in the binding reactions.
Fig. 4. E¡ect of overexpressed JNKBP1 on the JNK (A) and ERK
(B) cascades. A: COS-7 cells were transiently cotransfected with 0.3
Wg of 5XGAL4-LUC reporter, 0.03 Wg of GAL4-c-Jun expression
vector, and 0.03 Wg of Renilla luciferase (RL) control vector in the
absence or presence of 0.9 Wg of pcDNA3-Myc-JNKBP1, 0.06 Wg of
pcDNA3-His-S-MEKK1, or 0.2 Wg of pcDNA3-Flag-TAK1, as indi-
cated. B: COS-7 cells were transiently cotransfected with 0.3 Wg of
5XGAL4-LUC reporter, 0.03 Wg of GAL4-Elk1 expression vector,
and 0.03 Wg of RL control vector in the absence or presence of 0.9
Wg of pcDNA3-Myc-JNKBP1 or 0.2 Wg of pcDNA3-Flag-vRaf, as
indicated. Total DNA was kept at 1.5 Wg per transfection with
pcDNA3-Myc empty vector. 5XGAL4-driven luciferase activity was
normalized with RL activity. Bars represent the mean þ S.E.M.
(n = 3).
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interesting to examine whether JNKBP1 interacts with the
SEK1 and MKK7 MAPKKs, and the MEKK1, TAK1, and
MLK3 MAPKKKs in addition to the JNK MAPK.
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